Lv2
120 积分 2025-06-04 加入
Evaluation of Progression-Free Survival as a Surrogate End Point in Primary CNS Lymphoma: a Systematic Review and Meta-Analysis
1个月前
已完结
Recommendations for clinical research standards
5个月前
已完结
Batoclimab vs Placebo for Generalized Myasthenia Gravis
5个月前
已完结
Epidemiology of the idiopathic inflammatory myopathies
5个月前
已完结
Advances in the classification and management of idiopathic inflammatory myopathies
5个月前
已完结
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
6个月前
已完结
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
6个月前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
8个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
8个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
8个月前
已完结
皖公网安备34019202002308
